Shield Healthcare markets a broad range of disposable medical products and product-related services required for the treatment and care of patients in the home including incontinence, ostomy, nutrition, urology, and other products.
Trefethen professionals partnered with management to raise the requisite capital to fund a management buy-out.
Receivables were from state Medicaid programs and extended well beyond aging limits of most lenders.
Consideration included preferred equity with liquidation rights, complex conversion features and mandatory redemption rights.
Approached a very select group of non-traditional lenders and selected Healthcare Finance Group (“HFG”), as HFG was familiar with state Medicaid payment structures and could provide attractive lending terms and complete due diligence quickly.
HFG provided $12.3 million in the buyout and allowed the management team to acquire 100% of the common equity.
Advised management on and assisted in raising financing for buyout of controlling interest from Kobayashi Pharmaceuticals Co., Ltd.